Log in to save to my catalogue

Meningitic Escherichia coli -Induced Interleukin-17A Facilitates Blood-Brain Barrier Disruption via...

Meningitic Escherichia coli -Induced Interleukin-17A Facilitates Blood-Brain Barrier Disruption via...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2627871427

Meningitic Escherichia coli -Induced Interleukin-17A Facilitates Blood-Brain Barrier Disruption via Inhibiting Proteinase 3/Protease-Activated Receptor 2 Axis

About this item

Full title

Meningitic Escherichia coli -Induced Interleukin-17A Facilitates Blood-Brain Barrier Disruption via Inhibiting Proteinase 3/Protease-Activated Receptor 2 Axis

Publisher

Switzerland: Frontiers Research Foundation

Journal title

Frontiers in cellular neuroscience, 2022-02, Vol.16, p.814867-814867

Language

English

Formats

Publication information

Publisher

Switzerland: Frontiers Research Foundation

More information

Scope and Contents

Contents

Bacterial meningitis is a life-threatening infectious disease with high morbidity and mortality worldwide, among which meningitic
is a common Gram-negative pathogenic bacterium causing meningitis. It can penetrate the blood-brain barrier (BBB), invoke local inflammatory responses and consequently disrupt the integrity of the BBB. Interleukin-17A...

Alternative Titles

Full title

Meningitic Escherichia coli -Induced Interleukin-17A Facilitates Blood-Brain Barrier Disruption via Inhibiting Proteinase 3/Protease-Activated Receptor 2 Axis

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_journals_2627871427

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2627871427

Other Identifiers

ISSN

1662-5102

E-ISSN

1662-5102

DOI

10.3389/fncel.2022.814867

How to access this item